Company
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| TSRA-196 | Phase 1/2 | Alpha-1 Antitrypsin Deficiency (AATD) |
Latest
No recent events.
Follow Tessera Therapeutics, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.